1Sparsentan:a non-immunosuppressive drug treating IgA nephropathyJI Ya-chun, JIA Hui-xia, QI Jun-sheng225-2302Comprehensive efficacy evaluation system for stable coronary angina diseaseXU Jia-xin, DAI Xin-yue, ZHAO Yang, YU Bin-yang, GAO Rui231-2353Core technology topic identification and technology evolution trend analysis of non-small cell lung cancerYANG Feng, YUAN Hong-mei236-2434A β-lactamase inhibitor combination:sulbactam/durlobactamYANG Jun, LIU Fang, YU Ming-jie, CHENG Lin, CHEN Yong-chuan244-2485Overview of the British Pharmacopoeia 2024ZHAO Hui-fang, CHEN Wei-zhen, WANG Ya-wen249-2556Research on the optimization direction of drug review and approval based on continuous encouragement of innovationZHANG Xiao-yong, GAO Li-ping, NIU Jia-wei, LV Xin-huan, CHEN Sheng-xian, ZHANG Xiang-lin, WU Zhi-ang256-2637Research progress on new drugs derived from effective components of single herb of traditional Chinese medicineXIAO Wei-ting, ZENG Qiong-li, ZHANG Heng, HAN Yue, ZHOU Hua-rong, XIAO Xiao, WANG Xiong-long, LI Shun-xiang, OUYANG Wen264-2698Clinical research progress on Rh-endostatin in the treatment of nonsmall-cell lung cancerWANG Pei, ZHU Jian-bo270-2749Clinical observation of 341 cases of COVID-19 infection treated with a Tibetan medicine combination regimen in plateau regionsDUO Jie-tai, GESANG Yun-dan, ZHANG Qiong-wen, PINGCUO Duo-ji, WANG Bao, SUOLANG Ren-qing, SANG Dan, SHEN Yan-ru, LI Yan-jun, REN Qing-jia, DANSONG Zha-ba, BIANBA Ci-ren, TANG Jian-yuan, CHEN Wei-wu275-28110Clinical effect of compound Huangbai liquid on preventing postoperative complications of mandibular mesio-impacted third molarCHEN Lun-qiu, LI Zhi-cong, LIANG Huan-huan, LAN Li-yun, OUYANG Ke-xiong, PIAO Zheng-guo, CHEN Hao282-28511The requirements and analysis on the management of investigator-initiated trials for the high-quality development of research-oriented hospitalsLI Rao-yao, JIANG Ying-ping, HU Jun, DENG Yan-hong286-29112Clinical trial design and evaluation of traditional Chinese medicine in the treatment of adenoid hypertrophy in childrenLIU Ping, HU Si-yuan, CAI Qiu-han, LI Rui-ben, ZHOU Zi-nan292-29613Analysis,risk assessment,and theoretical maximum limit values of 40 elements in Shenmai GranulesLEI Rong, CAO Chun-qi, LIU Ya-ru, HAO Xiao-fei, LI Zhen, LIU Yong-li297-30314Study of ion distribution in microcrystalline cellulose and its correlation with conductivity using ion chromatographyLIU Jing-lan, WANG Jue, CHEN Hui-lin, ZHENG Shu-feng, YANG Rui, ZHAO Xia304-31115Determination of sorbitol content in compound amino acid injection(18AA)using high performance ion-exclusion chromatographyZUO Li-min, XIAO Jing, GUO Xin, ZHAO Ting, LIAN Xiao-fang, LIU Hui-yi, GU Yong-sheng, ZHOU Yi, SHAN Guang-zhi312-31616Simultaneous determination of five constituents in Wuwei Ganlu Yaoyu decoction powder by HPLCDING Yin, WANG Ya-qian, LUO Yu-ting, GOU Xiao-ling, WANG Tian-hong, FAN Gang317-32117Post-marketing safety study of amyotrophic lateral sclerosis therapeutics based on FAERSWANG Ling, LIU Lin-hui, PENG Hui, LI Xin-lin, LIU Mao-chang322-32918Evaluation of clinical rationality of omadacycline based on the attribute hierarchical modelXU Yang, HAN Li-zhuo330-336 